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Abstract
Echinococcosis notification rate in Greece, based on the most recent data, is below 0.25 per 100,000 population. To further
investigate the epidemiology of echinococcosis in Greece a study was designed to determine the seroprevalence of
Echinococcus granulosus antibodies in the population of Thessaly, Central Greece. Five hundred and forty two left over
blood samples in Thessaly laboratories, were collected using a stratified convenient sampling procedure. Samples were
analyzed with enzyme linked immunosorbent assay. The seropositivity found was 1.1%(95% C.I., 0.5–2.5), with 5 out of 6
seropositive results to be in the age group of over 65 (OR=17.95, 95%CI 2.04–157.11, p value 0.009). Rural residence was
also found as a risk factor to seropositivity (RR=7.60, 95% CI 0.89–64.64, p value 0.039). Surveillance data and our study
results converge that echinococcosis is being reduced in Greece, with older population to be affected mostly. These might
be due to the disease transmission restriction, by the control measures being implemented. Efforts should be continued, in
both animals and humans side, by increasing training campaigns and public awareness.
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Introduction
Echinococcus granulosus has a worldwide distribution and is
responsible for 95% of echinococcosis cases in humans worldwide.
The Echinococcus’ main intermediate host is the sheep and the
parasite has as point of localization, the liver and the lungs. The
practice of dogs being fed with offal from ruminant livestock
originating from illegal slaughtering is the main mode of
transmission of Echinococcus. Humans are infected with contami-
nated food or water with dog faeces. Cases of human infection
have been reported in the age from 1 to 75 years. Rural residence
has been reported as an associated factor to echinococcosis.
Infection rates do not differ between sexes, while 60% of the
infected population remains asymptomatic forever [1,2].
Echinococcosis incidence has been dramatically reduced in
Greece but is not eradicated. Echinococcosis notification rate in
Greece, based on the most recent data, is below 0.25 per 100,000
population [3]. Surveillance data, as reported by the competent
authorities for the decade 1998–2009, reveal that the cases in
Thessaly were 16 in total, with the latest case to be reported in
2003. According to these data, 8 cases were over 50 years old, 3
below 37 years old and 5 had no age reported. Ever since the
Echinococcus control programme has been introduced in Greece,
echinococcosis incidence has been decreased from 1.000 cases per
year during the 80 s to 421 for the decade1998–2009 [4].
The aforementioned surveillance data though, might be
misleading as long asymptomatic period is related to echinococ-
cosis, and additionally the surveillance system in Greece suffers
from underdiagnosis and underreporting [5].
To further investigate the epidemiology of echinococcosis, a
study was designed to determine the seroprevalence of Echinococcus
granulosus antibodies in the population of Thessaly, Central Greece,
which is a predominantly agricultural region.
Methods
During April to May 2009, a total of 542 left over blood samples
were collected from public and private laboratories in the region of
Thessaly and all of them were anonymous. Approval to use these
samples was received by the Scientific Committee of the Post
graduate Program in ‘‘Public Health and Environmental Hy-
giene’’, University of Thessaly. After verbal consent was acquired,
anonymous left over blood samples were collected and sent to the
Department of Microbiology, General University Hospital of
Larisa, Greece. For calculating the needed sample, we used as
expected prevalence 1% (60.7%) at a confidence level of 90%.
The sample was stratified according to the population of the
prefectures (Larissa, Trikala, Karditsa), residence (rural/urban),
sex (male/female) and age group (0–14, 15–24, 25–34, 35–44, 45–
54, 55–64, 65–74, .74). The left over sampling methodology
implemented was based on the sampling methodology described
by ESEN2 network (European Seroepidemiology Network) [6].
This way of sampling has the advantage of being of low cost and
with sufficient representativeness. From each participating labo-
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samples fulfilling the inclusion criteria (age, sex, residence)
according to the population of each prefecture. The samples were
collected prospectively in three months period, while people were
using the laboratory services for other purposes: checkups, other
illness examinations etc.
An enzyme linked immunosorbent assay (Virion/Serion) was
used to detect anti-Echinococcal IgG antibodies. The analysis was
performed in the Department of Microbiology, General University
Hospital of Larissa. Data were analyzed using the statistical
package SPSS (v. 15). Fisher’s exact test was used for qualitative
data. Logistic regression analysis was used to control for
confounders. Results were considered statistically significant when
the p value was #0.05.
Results
Out of 542 serum samples 6 (1.1%) were found positive for
Echinococcus granulosus IgG antibodies. The descriptive characteris-
tics of the samples in terms of gender, region, place of residence
and age group are being presented in Table 1. Univariate
statistical analysis was conducted with relation to gender, residence
and age. As shown in Table 2, there was no statistically significant
difference between men and women, while rural residence was
found as a risk factor to seropositivity (RR=7.60, 95% CI 0.89–
64.64, p value 0.039). Finally in relation to the age group, 5 out of
6 positive samples belonged to the group 65–74 years. Multiple
logistic regression analysis conducted, indicated that the most
important factor affecting the results of this study was the age, with
the age group of 65 and above to significantly have higher
seropositivity (OR=17.95, 95%CI 2.04–157.11, p value 0.009)
(Table 3).
Discussion
The seropositivity of Echinococcus granulosus in Central Greece
was found 1.1% (0.5–2.5), results that could be considered in line
to the surveillance data for Thessaly, for the decade 1998–2009.
The multivariate analysis conducted in our study, revealed that the
main affecting factor for the results was age, with age group of 65
and above to significantly associate with the seropositivity. This
could be explained by the increased possibility to acquire
antibodies against Echinococcus granulosus as age is progressing,
without though necessarily developing the illness [3]. Moreover, it
has been reported that only 10–20% of the diagnosed cases are
under the age of 16 years [1]. The absence of cases and
seropositive results in younger population may be also related to
the reduction of the disease transmission, due to the control
measures taken. The implementation of stricter regulations (E.C.
Regulation 1774/2002) in relation to by products handling in the
abattoirs has assisted this progress in Echinococcus control. Now-
days, the abattoir by products are being incinerated and by this
way stray dogs cannot access them. As a result the biological cycle
of Echinococcus is being restricted.
Another risk factor identified in our study, was the rural
residence. Rural areas present an increased number of seropositive
persons that is closely related to Echinococcus biological cycle.
Greece has increased number of sheep and goat farms and the
Echinococcus prevalence in livestock is 23–39.2% in sheep and 7.6–
Table 1. Sample Descriptive Characteristics.
Characteristics n/Total (N=542) (%)
Sex
Male 277 (51.1)
Female 265 (48.9)
Area
Karditsa 122 (22.5)
Larisa 286 (52.8)
Trikala 134 (24.7)
Residence
Urban 327 (60.3)
Rural 215 (39.7)
Age group
0–14 86 (15.9)
15–24 70 (12.9)
25–34 75 (13.8)
35–44 73 (13.5)
45–54 69 (12.7)
55–64 67 (12.4)
65–74 66 (12.2)
.74 36 (6.6)
doi:10.1371/journal.pone.0037112.t001
Table 2. Univariate Analysis.
Risk Factor Sample value (.=15)
N/Total (%)
RR
(95% CI) P-value*
Sex 0.364
Male 4/277 (1.4) 1.91
Female 2/265 (0.8) (0.35–10.36)
Residence 0.039
Rural 5/215(2.3) 7.60
Urban 1/327 (0.3) (0.89–64.64)
Age Group 0.001
$65 5/102 (4.9) 21.57
,65 1/440 (0.2) (2.55–182.63)
*: Fisher’s Exact test.
doi:10.1371/journal.pone.0037112.t002
Table 3. Multivariate Analysis.
Self-reported risk factor Sample value (.=15)
OR
(95% CI) P-value
Sex 1.70 0.551
Male/Female (0.30–9.75)
Residence 4,96 0.151
Rural/Urban (0.56–44.15)
Age Group 17,95 0.009
$65/,65 (2.04–157.91)
doi:10.1371/journal.pone.0037112.t003
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regularly dewormed and therefore it was expected to have higher
prevalence in rural areas as reported by others [1].
Similar studies have been conducted in other European
countries and the concluding remarks were in agreement with
ours. In a study performed in Spain in 2003, anti Echinococcal
antibody seroprevalence was found 3.4% and was significantly
associated with age [8]. Another study conducted in Slovenia in
2008, concluded that the decrease of echinococcosis reported was
mainly related to the control of Echinococcus in livestock [9].
According to the official data of the Hellenic Centre of Disease
Control and Prevention [5], a decreasing trend in Echinococcus
prevalence is being observed. Our study supports the above
findings, alongside with a previous study in the same area, that
determined ultrasonograhic prevalence of Echinococcus [10].
Moreover, similar results were found in a study in the island of
Crete, that determined Echinococcous seroprevalence with counter-
immunoelectrophoresis (CIE) [11].
Limitations of our study might have been the sampling and the
method of antibody detection used. To facilitate the sample
collection, we decided to use the methodology of left over blood
samples, as used in similar seroprevalence studies [12]. Neverthe-
less, the sampling methodology implemented, could be considered
as a convenient sample, stratified according to age, sex and
residency of the total population in each prefecture. Major
advantages of this sampling technique are the limited cost and the
possibility of repeating the study using the same methodology to
identify trends. A possible limitation of this sampling methodology
is the lack of randomization, challenging the representativeness of
the sample.
Regarding the method of antibody detection limitation, serum
tests are not considered to be 100% sensitive and specific.
Moreover the ELISA test specificity and selectivity relies mainly
upon the kit used and more specifically on the antigen source used.
A wide range from 31 to 96% for sensitivity and from 40–100%
for specificity of ELISA kits has been reported [13,14]. IgG
antibodies production mainly depends on the number, the size, the
topography and the hydatides cysts condition [1]. No production
of antibodies has been also reported when small cysts, intact cysts
and other highly calcified cysts exist [15]. Specificity issues on the
other hand, might be as well complicated, when cross-reactions
take place with other types of Echinococcus or in patients with
cysticercosis [16]. Nonetheless, the ELISA test by detecting IgG
antibodies shows previous contact with Echinococcus granulosus,
without though confirming the illness.
Surveillance data and our study results converge that echino-
coccosis is being reduced in Greece, with older population to be
affected mostly. These might be due to the disease transmission
restriction, by the control measures being implemented. Efforts
should be continued, in both animals and humans side, by
increasing training campaigns and public awareness.
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